RxDoctor Payments Data

Alfonso Barragan, MD

Surgery of the Hand · Burleson, TXNPI 1851433775

Payments from drug & device makers

What this record shows

Almost everything reported here is food and beverage — 98.9% of the total across 37 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 14 manufacturers reported payments, led by Pylant Medical at 33.9% of the total. That places this record below the midpoint for surgery of the hand clinicians in TX, where the typical reported total is $2,480.

$1,233in general payments, 2019–2025

Across 37 payments — averaging $33.33 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Pylant Medical$418
  • Amgen$217
  • Acumed LLC$138
  • Pacira Therapeutics, Inc.$87
  • Bioventus LLC$69
  • Kerecis Limited$58
  • plus $246 from 8 others

What the payments were for

  • Speaking & faculty fees$141%
  • Food & beverage$1,22099%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
21
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Pylant Medical5$418
Amgen(2 entities)12$217
Acumed LLC1$138
Pacira Therapeutics, Inc.2$87
Bioventus LLC4$69
Kerecis Limited2$58
Vertex2$52
Innovation Technologies Inc2$50
Endo Pharmaceuticals Inc.2$39
Stryker1$28
Dynasplint Systems Inc.1$23
Exsomed Corporation1$20
Axogen1$17
Merck1$17

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,233 in reported general payments places this provider in the 25th percentile of 68 surgery of the hand providers in Texas.

See all surgery of the hand providers in Texas

Medicare billing

Part B allowed, 2024
$133,895
Medicare patients
250
Services billed
7,205

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Methylprednisolone208$1,776
Celecoxib73$1,511
Hydrocodone-AcetaminophenHydrocodone/Acetaminophen140$1,371
Meloxicam162$467
Tramadol Hcl39$221
Naproxen12$78

Paid to pharmacies, not to this prescriber.

Other surgery of the hand in Burleson

See the full list for Texas

Where these figures come from

Is this you, or does something look wrong? →